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Definition   
Diseases of the Adrenal Glands 
• Diseases of the Adrenal Glands are conditions that interfere 
with the normal functioning of the adrenal glands and may 
cause hyperfunction (Overactive Adrenal Glands) or 
hypofunction (Underactive Adrenal Glands), and may be 
congenital or acquired. 
• There are two parts of the adrenal glands, the cortex, derived 
from mesenchymal cells, and the medulla, derived from 
neuroectodermal cells; first one produces mineralocorticoids, 
glucocorticoids, and androgens; and second one produces 
epinephrine (adrenaline) and norepinephrine(noradrenaline).  
https://en.wikipedia.org/wiki/Adrenal_gland_disorder 
Epidemiology 
Epidemiologic study of adrenal gland disorders in Japan 
• The total numbers of patients in 
Japan in 1997 were estimated as 
1,450 for primary aldosteronism, 
1,250 for Cushing's syndrome, 
290 for adrenal preclinical 
Cushing's syndrome, 660 for 
Addison's disease, and 1,030 for 
pheochromocytoma 
• For the first time, a reliable 
national estimation of the 
prevalence of disorders of adrenal 
hormones was conducted in this 
study 
http://www.eurorad.org/eurorad/view_figure.php?pubid=11230&figid=34889&nr=1&lang=en  http://www.ncbi.nlm.nih.gov/pubmed/10915016 
Abdominal ultrasonography 
revealed a 5cm 
heterogeneous nodule in 
the right adrenal gland 
Risk Factors    
• There does not appear to be a particular group who is most 
at risk for adrenal gland disorders 
• While there are certain risk factors for adrenal gland 
disorders, most of them occur without apparent cause, 
where risk factors are absent 
• The risk of development adrenal diseases may be increased 
by genetic predisposition; by a problem in another gland, 
such as the pituitary gland, or when a disease or infection 
affects one or both of the adrenal glands; and certain 
lifestyle behaviors and environmental factors, such as 
smoking and exposure to carcinogens  
• Adrenal gland disorders appear to affect men, women, and 
children equally and may develop at any age. 
http://www.cancercenter.com/adrenal-cancer/risk-factors/ sharecare.com/health/adrenal-gland/who-risk-adrenal-gland-disorders 
Etiology  
• Congenital anomalies (genetic mutations) 
• Immunopathology  
• Infections (e.g., tuberculosis, acquired immune 
deficiency syndrome (AIDS)) 
• A problem in another glands, such as the 
pituitary, which regulate the adrenal gland 
• Tumors including pheochromocytomas 
• Bilateral adrenal hemorrhage or infarction 
• Bilateral adrenalectomy 
• Certain medicines 
https://medlineplus.gov/adrenalglanddisorders.html 
Mechanisms  
• The major disorders of the adrenal cortex are characterized by 
excessive or deficient secretion of each type of adrenocortical 
hormone accordingly to interference of etiologic and 
pathogenetic factors that include distress,  injury, vascular 
reactions, thrombosis, necrosis, acute and chronic  
inflammation, dystrophy, hypertrophy,   neoplastic processes, 
etc. 
• The most common disorder of the adrenal medulla is 
pheochromocytoma, that originates from chromaffin cells and 
excretes catecholamines, but pheochromocytoma may be 
referred to as secreting paragangliomas when found in extra-
adrenal chromaffin cells; neoplasms, such as neuroblastomas 
and ganglioneuromas, may also be of neuronal lineage.  
 http://accessmedicine.mhmedical.com/content.aspx?bookid=339&sectionid=42811321 ncbi.nlm.nih.gov/pmc/articles/PMC2576282/ 
International Classification of Diseases 
http://apps.who.int/classifications/icd10/browse/2016/en#/E00-E07 
Chapter IV 
(E00-E90) Endocrine, nutritional and metabolic diseases 
 (E20-E35) Disorders of other endocrine glands 
 E26 Hyperaldosteronism: E26.0 Primary 
hyperaldosteronism, E26.1 Secondary hyperaldosteronism, 
E26.8 Other hyperaldosteronism (Bartter syndrome), 
E26.9 Hyperaldosteronism, unspecified 
 E27 Other disorders of adrenal gland: E27.0 Other 
adrenocortical overactivity, E27.1 Primary adrenocortical 
insufficiency, E27.2 Addisonian crisis, E27.3 Drug-induced 
adrenocortical insufficiency, E27.4 Other and unspecified 
adrenocortical insufficiency, E27.5 Adrenomedullary 
hyperfunction, E27.8 Other specified disorders of adrenal 
gland, E27.9 Disorder of adrenal gland, unspecified 
Clinical classification 
   • Adrenal Insufficiency (AI) 
• Adrenal Hyperfunction (AH) 
• Primary Hyperaldosteronism 
• Glucocorticoid-Remediable 
Hyperaldosteronism 
• Pheochromocytoma 
• Adrenal Hyperandrogenism 
• Nonclassic Congenital Adrenal 
Hyperplasia 
• Androgen-Secreting Adrenal Tumors 
• Adrenal Incidentaloma 
• Considerations of the Pharmacologic 
use of Glucocorticoids 
http://www.hormone.org/ clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Adrenal Insufficiency 
Etiology  of Primary Adrenal Insufficiency  
• The most common cause of primary adrenal insufficiency (AI) 
is autoimmune destruction of the adrenal glands (Addison’s 
disease - 70%-90% of all causes 
• Some other causes of primary AI include bilateral adrenal 
hemorrhage, drugs (e.g., mitotane, etomidate, ketoconazole), 
infectious diseases (e.g., tuberculosis, HIV infection, 
disseminated histoplasmosis, paracoccidiomycosis)) affects 
glucocorticoid and mineralocorticoid secretion and may be 
fatal if untreated 
• Addison’s disease may coexist with other autoimmune 
conditions, such as type 1 diabetes, hypothyroidism, or 
hypoparathyroidism.  
clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Adrenal Insufficiency 
Etiology  of Secondary and Tertiary Adrenal Insufficiency  
• Secondary and tertiary AI occur commonly after the 
discontinuation of glucocorticoids 
• Less frequently, adrenocorticotropic hormone (ACTH) 
deficiency may be caused by pituitary macroadenomas, 
pituitary surgery or radiation, and parasellar diseases 
• Megestrol acetate, an appetite stimulator used in some 
patients with advanced cancer or cachexia related to AIDS may 
be associated with secondary AI 
• Tertiary AI results from the inadequate secretion of 
corticotropin-releasing hormone (CRH0 
•  Secondary and tertiary AI only affect cortisol secretion, 
because ACTH has only a minor role in regulation of 
aldosterone secretion. 
clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Adrenal Insufficiency 
Manifestations 
• All patients with primary AI complain of fatigue, anorexia, and 
weight loss; skin hyperpigmentation, initially on the extensor 
surfaces, palmar creases, and buccal mucosa, results from 
increased levels of ACTH and other pro-opiomelanocortin–
related peptides, including melanocyte-stimulating hormone 
• Secondary AI manifests more insidiously with lack of skin 
hyperpigmentation, salt craving, metabolic acidosis, and 
hyperkalemia, because mineralocorticoid secretion is intact; 
fatigue, hyponatremia, and hypoglycemia are some of the 
clinical manifestations in secondary adrenal insufficiency. 
 
 
clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Adrenal Insufficiency 
Symptoms, Signs and Laboratory Abnormalities 
Symptoms 
• Weakness, fatigue 
• Anorexia 
• Nausea 
• Vomiting 
• Constipation 
• Diarrhea 
• Abdominal pain 
• Salt craving 
• Postural dizziness 
• Muscle and joint 
pain 
clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Signs  
• Weight loss 
• Hyperpigmentation 
• Vitiligo 
• Systolic blood pressure <110 mm Hg 
Laboratory Abnormalities 
• Hyponatremia 
• Hyperkalemia 
• Hypercalcemia 
• Azotemia 
• Anemia 
• Eosinophilia 
Adrenal Insufficiency 
Symptoms, Signs and Laboratory Abnormalities 
https://healedbybacon.files.wordpress.com/2015/11/addisons.png?w=607&h=661 
Adrenal Insufficiency 
Evaluation 
Evaluating a patient with 
suspected AI is a three-step 
process:  
• Establishing the diagnosis 
• Differentiating between 
primary and secondary 
adrenal insufficiencies 
• Looking for the cause of 
adrenal insufficiency. 
http://www.prn.org/images/uploads/85_brown_todd_fig1-680.gif clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Adrenal Insufficiency 
Diagnosis 
• An early morning (8 am) plasma 
cortisol level lower than 3 μg/dL 
confirms AI, whereas a value 
higher than 15 μg/dL makes the 
diagnosis highly unlikely 
• Cortisol levels in the range of 3 to 
15 μg/dL may be seen in patients 
with primary, secondary, or 
tertiary adrenal insufficiency  
• These patients should be 
evaluated by the cosyntropin 
(Cortrosyn) stimulation test (CST) 
at any time during the day. 
clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Adrenal Insufficiency 
Differentiation Primary and Secondary Adrenal Insufficiencies 
• Differentiation Between 
Primary and Secondary AI 
is done through the 
measurement of the basal 
plasma ACTH level 
• An elevated ACTH level is 
consistent with primary AI 
• A low or normal-range 
ACTH level, with a low 
cortisol level, confirms the 
diagnosis of secondary or 
tertiary AI. 
https://courses.washington.edu/conj/bess/feedback/cortisol/cortisoldisorders.html clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Adrenal Insufficiency 
Determining the Cause of Adrenal Insufficiency 
• When the biochemical workup is consistent with primary AI, 
computed tomography (CT) scanning of the adrenal glands may 
help with the differential diagnosis 
• Enlarged adrenal glands or calcifications suggest an infectious, 
hemorrhagic, or metastatic cause 
• In rare circumstances, CT-guided percutaneous fine-needle 
aspiration of enlarged adrenal glands may help establish the 
diagnosis 
• Patients with tuberculous AI usually have evidence of active 
systemic disease 
• Magnetic resonance imaging (MRI) of the pituitary gland is 
indicated if glucocorticoid therapy as the cause of the 
secondary AI has been ruled out. 
https://clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Adrenal Insufficiency 
Treatment 
• Patients with Addison’s disease require lifelong replacement 
with glucocorticoids and mineralocorticoids; the dose is 
adjusted based on clinical status, including the presence or 
absence of orthostatic hypotension, hypertension, and 
electrolyte imbalance 
• Patients with secondary or tertiary adrenal insufficiency do 
not need mineralocorticoid replacement 
• Most patients can be educated to self administer 
hydrocortisone, and reduce the risk of an emergency room 
visit 
• All patients should wear some form of identification 
indicating their adrenal insufficiency status. 
https://clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Adrenal Insufficiency 
Alert Medical ID 
For patients with AI, medical  identification (ID) necklaces or 
bracelets are absolutely essential with information of their 
diagnosis and treatment regimen.   
s-media-cache-ak0.pinimg.com/736x/ca/e6/1f/cae61f17ec45a8c94cac00ef6be4af62.jpg s-media-cache-ak0.pinimg.com/236x/28/d8/d5/28d8d55e4765ff4a30ed0473ddbc8 
.laurenshope.com/stainless-red-oval-medical-id-tag? clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Adrenal Insufficiency 
Adrenal Crisis 
• Adrenal crisis (acute AI) is a life-threatening emergency, which 
usually manifests with nausea, vomiting, abdominal pain, 
abdominal tenderness, fever, acute abdomen and shock 
• Patients may be previously undiagnosed or have chronic 
primary AI, with no or inadequate glucocorticoid replacement 
• Treatment of adrenal crisis should not be delayed 
• Diagnostic workup in a patient with no history of AI should 
include a plasma sample for cortisol and ACTH level 
determination, immediately followed by an intravenous (IV) 
bolus of hydrocortisone, 100 mg, and adequate fluid 
replacement (normal saline) 
• Hydrocortisone should be continued, 50 mg every 8 hours, while 
awaiting laboratory results. 
https://clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Adrenal Insufficiency 
Adrenal Insufficiency in the Critically Ill Patient 
• The overall incidence of AI in critically ill patients is less than 
10%, but an incidence as high as 50% in a patient with septic 
shock has been reported 
• Intensive care unit (ICU) patients with hemodynamic instability, 
despite fluid resuscitation (especially in the presence of shock), 
should be tested for AI 
• Hydrocortisone, 50 mg IV every 6 to 8 hours is an adequate 
replacement dose for critically ill patients with suspected AI 
• Treatment with this dose should be continued for 2 or 3 days 
• After hemodynamic improvement, a gradual taper of 
hydrocortisone, depending on the patient’s condition, should be 
instituted. 
https://clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Adrenal Hyperfunction 
Selected List of Related Disorders 
• Disorders related to adrenal hyperfunction (AH) are relatively 
rare, but they have significant mortality and morbidity if 
untreated 
• When the adrenal glands produce too many hormones, the 
symptoms vary depending on the disorder 
• Disorders related to AH include:  
• Cushing’s syndrome   
• Primary hyperaldosteronism  
• Pheochromocytoma/Paraganglioma 
• Hormonally Active Tumors. 
https://clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Adrenal Hyperfunction 
Cushing’s Syndrome: Definition and Classification 
    
• Cushing’s syndrome (CS) is 
composed of symptoms and 
signs associated with prolonged 
exposure to inappropriately 
high levels of plasma 
glucocorticoids 
• Exogenous glucocorticoid 
intake is the most common 
cause of CS 
• The endogenous causes are 
divided into ACTH-dependent 
and ACTH-independent CS. 
https://csrf.net/wp-content/uploads/2013/06/symptoms.gif clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Adrenal Hyperfunction 
Cushing’s Syndrome: Etiology of Endogenous Form 
clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland 
ACTH-Dependent 
                              Cushing's syndrome (67%) 
                              Ectopic ACTH secretion (12%) 
                              Ectopic CRH secretion (<1%) 
ACTH-Independent 
                              Adrenal adenoma (10%) 
                              Adrenal carcinoma (8%) 
                              Micro-and macronodular adrenal hyperplasias (1%) 
Adrenal Hyperfunction 
Cushing’s Syndrome: Clinical Features 
http://img.medscape.com/fullsize/migrated/474/901/nf474901.tab1.gif 
Adrenal Hyperfunction 
Symptoms, Signs and Laboratory Abnormalities 
https://thumbs.dreamstime.com/z/cushings-disease-syndrome-signs-symptoms-cushing-s-labeled-human-silhouette-internal-organs-vector-illustration-55259613.jpg 
Adrenal Hyperfunction 
Cushing’s Syndrome: Establishing the Diagnosis   
• UFC - 24-hour urinary free 
cortisol determination 
• DST - 1-mg 
dexamethasone 
suppression test 
• Midnight salivary cortisol 
test  
• LDDST - low dose 
dexamethasone 
suppression test 
• IPSS - International 
Prognostic Scoring System  
clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Adrenal Hyperfunction 
Cushing’s Syndrome: Differential Diagnosis 1   
• Once CS is biochemically confirmed, the plasma ACTH level 
should be measured, preferably in the morning 
• A suppressed or low ACTH level (<10 pg/mL) is consistent with 
ACTH-independent CS and should be followed by adrenal CT 
scanning 
• ACTH values of 10 to 20 pg/mL may be seen in patients with 
both adrenal and pituitary causes for CS; these patients should 
undergo a CRH stimulation test 
• A flat response of ACTH to CRH during the test suggests an 
adrenal cause, but a more than 50% increase in the ACTH level 
during the test is consistent with Cushing’s disease 
• ACTH levels higher than 20 pg/mL suggest ACTH-dependent CS.   
clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Adrenal Hyperfunction 
Cushing’s Syndrome: Differential Diagnosis 2   
• About 90% of patients with ACTH-dependent CS have a pituitary 
cause and the rest are ectopic in origin 
• ACTH levels tend to be higher in ectopic CS compared with 
Cushing’s disease, but there is significant overlap  
• A more than 50% increase in the ACTH level after the CRH test 
and more than an 80% reduction in the morning cortisol level 
(8-9 am) after taking 8 mg dexamethasone at 11 pm during a 
high-dose DST is consistent with a pituitary source, and in the 
presence of a pituitary adenoma, almost establishes the 
definitive diagnosis of CS.  
clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Adrenal Hyperfunction 
Cushing’s Syndrome: Differential Diagnosis 3 
• . If the CRH stimulation test and DST results are not concordant 
and MRI does not show a pituitary adenoma, then inferior 
petrosal sinus sampling to distinguish ectopic from Cushing’s 
disease is indicated 
• Localizing tumors that produce ectopic ACTH is accomplished by 
chest and abdominal CT studies, followed by neck CT if no 
source is found 
• An octreotide scan may be of some value in patients with 
ectopic CS and negative imaging studies. 
clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Adrenal Hyperfunction 
Cushing’s Syndrome: Treatment 
• Surgical (trans-sphenoidal) removal of the ACTH-secreting pituitary 
tumor is the treatment of choice 
• CS caused by an adrenal adenoma is usually cured by laparoscopic 
unilateral adrenalectomy 
• Adrenal carcinoma is an aggressive tumor with a poor prognosis; 
surgical resection at an early stage, along with lifelong mitotane 
therapy soon after surgery, offers the only chance for cure or long-
term remission  
• Surgical removal of an ectopic ACTH-producing tumor results in cure 
• Medical therapy with ketoconazole, metyrapone, 
aminoglutethimide, or mitotane may be considered for patients 
with a limited life expectancy or for alleviation of hypercortisolemic 
symptoms before surgery. 
clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Primary Hyperaldosteronism 
Prevalence   
• Conn first described primary hyperaldosteronism (PH) in 1955 in a 
patient with an adrenal adenoma 
• A prevalence as high as 10% in hypertensive patients, and women in 
their fourth to sixth decade of life are affected more often than men 
• A solitary aldosterone-producing adenoma (65%) and bilateral 
idiopathic hyperplasia (30%) are the most common subtypes of PH 
• The adenomas are usually benign and smaller than 2 cm in diameter 
• Idiopathic adrenal hyperplasia may be accompanied by 
adrenocortical nodules and is associated with lower aldosterone 
levels and less severe hypertension, compared with adenomas.  
clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Primary Hyperaldosteronism 
Causes 
http://images.slideplayer.com/26/8443752/slides/slide_15.jpg 
Primary Hyperaldosteronism 
Forms of Familial Hyperaldosteronism 
Two forms of familial primary  hyperaldosteronism (FH) have been 
described:  
• FH type I, or glucocorticoid-remediable hyperaldosteronism (GRH), 
is an autosomal dominant disease characterized by a chimeric gene 
between the 11β-hydroxylase and aldosterone synthase, with 
varying degrees of hyperaldosteronism, which responds to 
exogenous glucocorticoids 
• FH type II is an autosomal dominant disorder of both the 
aldosterone-producing adenoma (APA) and idiopathic 
hyperaldosteronism (IHA). 
clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Primary Hyperaldosteronism 
Clinical Presentation 
• The clinical picture varies from asymptomatic to symptoms related 
to hypertension, hypokalemia, or both 
• Patients may have headaches, polyuria, nocturia, polydipsia, 
parasthesias, weakness, and muscle cramps 
• There are no specific physical findings 
• The degree of hypertension is usually moderate to severe, and may 
be refractory to conventional antihypertensive agents 
• Malignant hypertension and leg edema are rare 
• The left ventricular hypertrophy is disproportionate to the level of 
blood pressure and improves after treatment of PH, even if 
hypertension persists.   
clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Primary Hyperaldosteronism 
Signs and Symptoms 
http://www.cell.com/cms/attachment/2007953169/2030530657/gr2.jpg 
Primary Hyperaldosteronism 
laboratory Tests 
• Routine laboratory tests may show slightly high serum sodium levels 
(143-147 mEq/L), hyperglycemia, hypokalemia, metabolic alkalosis, 
and hypomagnesemia 
• Although most patients with hyperaldosteronism are not 
hypokalemic, a low serum potassium level may be noted, either 
spontaneously or after thiazide or loop diuretic use 
• Hypokalemia may be severe and difficult to correct 
• Hypokalemia presence reduces the secretion of aldosterone and 
thus should be corrected before the laboratory evaluation of 
hyperaldosteronism. 
clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Primary Hyperaldosteronism 
Diagnosis 
• The workup of a patient for PH 
involves the following steps: 
screening tests for PH, establishing 
the autonomy of aldosterone 
secretion, and determination of the 
source of hyperaldosteronism  
• The categories of patients: 
– hypertensive with spontaneous 
or thiazide-induced hypokalemia 
– hypertensive resistant to therapy 
– hypertensive with adrenal 
incidentalomas. 
 
clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Primary Hyperaldosteronism 
Diagnosis 
Adrenal adenoma on Computer Tomography 
http://columbiasurgery.org/conditions-and-treatments/primary-hyperaldosteronism-conns-syndrome 
Primary Hyperaldosteronism 
Screening Tests 
• Although hypokalemia in a hypertensive patient is suggestive of 
hyperaldosteronism, normokalemia does not exclude the diagnosis 
• Measurement of the 24-hour urinary potassium level can be useful 
in assessing the cause of a low potassium level 
• Urinary potassium excretion >30 mEq/24 hours in a patient with 
hypokalemia suggests PH, if plasma renin activity (PRA) is low 
• The ratio of the plasma aldosterone concentration (PAC) to PRA 
(PAC/PRA) is the best screening test for PH 
• Spironolactone and eplerenone should be discontinued for 6 weeks 
before testing 
• Low or suppressed PRA during therapy with angiotensin-converting 
enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) 
suggests hyperaldosteronism. 
clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Primary Hyperaldosteronism 
Differentiating Aldosterone-Producing Adenoma From 
Idiopathic Hyperaldosteronism 
clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Parameter APA IHA 
HTN, potassium 
concentration [K+] 
HTN more severe, 
higher likelihood of 
hypokalemia 
HTN less severe, less 
likelihood of 
hypokalemia 
Upright posture test 
Decrease or <30% 
increase of serum 
aldosterone level 
Increase by >30% of 
serum aldosterone 
level 
18-Hydroxycorticosterone >100 ng/mL <100 ng/mL 
Computed tomography 
scan 
>1-cm adrenal 
tumor, with normal 
contralateral 
adrenal 
No adrenal tumor, 
bilateral thickening 
of adrenals 
Bilateral adrenal venous 
sampling Lateralization No lateralization 
APA, aldosterone-producing adenoma; HTN, hypertension; IHA, 
idiopathic hyperaldosteronism  
 
Primary Hyperaldosteronism 
Medical History, Clinical Findings, and Screening Work-Up  
Patient with suspected 
primary aldosteronism. PRA, 
plasma renin activity; PAC, 
plasma aldosterone 
concentration; ARR, 
aldosterone–renin ratio; 24 h-
ABPM, 24 h ambulatory blood-
pressure monitoring; LV, left 
ventricular; K+, potassium; Na+, 
sodium; Mg2+, magnesium; 
APA, aldosterone-producing 
adenoma; IHA, idiopathic 
hyperaldosteronism. 
http://eurheartj.oxfordjournals.org/content/35/19/1245 
Primary Hyperaldosteronism 
Treatment  
• The treatment goals are to reduce the morbidity and mortality   
• Unilateral adrenalectomy results in normalization of hypokalemia 
and improvement in hypertension in all patients 
• Medical treatment is reserved for patients with IHA or those with 
APAs who are poor surgical candidates 
• Spironolactone or Eplerenone is the treatment of choice 
• Side effects include painful gynecomastia, nausea, headaches, 
impotence, and irregular menstruation; Eplerenone that blocks the 
aldosterone receptor selectively has a better side effect profile  
• The use of a mineralocorticoid is usually not necessary. 
clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Primary Hyperaldosteronism 
Diagnosis and Treatment Algorythm 
https://s3.amazonaws.com/classconnection/949/flashcards/3738949/jpg/hy-14926404BA85D6DBA4F.jpg 
Primary Hyperaldosteronism 
Glucocorticoid-Remediable Hyperaldosteronism 
• Familial hyperaldosteronism type I, or glucocorticoid-remediable 
hyperaldosteronism (GRH) individuals are  younger  40 years, exhibit 
hypertension resistant to standard therapy, and have a family 
history of primary hyperaldosteronism or a cerebrovascular 
accident at a young age 
• Most  have a normal serum potassium level  
• A very high urinary 18-hydroxycortisol level (>3000 nmol/24 hr) or 
genetic testing to detect a chimeric gene establishes the diagnosis 
• Affected individuals should have neurovascular screening for 
cerebral aneurysms 
• Treatment with glucocorticoids, eplerenone, spironolactone, 
amiloride, and triamterene is effective.   
clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Pheochromocytoma 
Definition 
• Pheochromocytomas 
(PHEOs) are rare chromaffin 
cell tumors that may occur at 
any age 
• Although their true 
prevalence is unknown, they 
occur in about 0.3% of 
hypertensive patients 
• If untreated, PHEOs can have 
severe consequences, such 
as myocardial infarction, 
heart failure, cerebrovascular 
accident, and death. 
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Pheochromocytoma 
Anatomic Considerations and Etiology 
• Most PHEOs are benign, sporadic, unilateral, and located within 
the adrenal gland 
• Extra-adrenal PHEOs (paragangliomas) occur in about 15% of 
cases in the superior and inferior para-aortic areas, including the 
Zuckerkandl organ, bladder, thorax, and head, neck, and pelvis 
• Paragangliomas tend to occur in younger patients <20 years); 
they are multifocal in about 15% to 30% of cases 
• Bilateral PHEOs are usually seen as part of familial syndromes 
• Malignant PHEOs have a higher prevalence in ectopic PHEOs and 
lower prevalence in familial PHEOs  
• About 10% to 15% of PHEOs are hereditary in nature.  
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Pheochromocytoma 
Clinical Manifestations 
• Patients with PHEO may have paroxysmal hypertension (48%) or 
persistent hypertension (29%), or be normotensive (13%). 
• Wide fluctuations in blood pressure and resistance to 
antihypertensive medications are typical of those with PHEO  
• The triad of headaches, palpitations, and diaphoresis suggests the 
diagnosis of PHEO, but absence of these symptoms does not 
exclude the disease 
• Attacks are usually precipitated by emotional stress, exercise, 
anesthesia, abdominal pressure, or ingestion of tyramine- 
containing foods 
• Symptoms include pallor, flushing, orthostatic hypotension, weight 
loss, dyspnea, polyuria, polydipsia, visual blurring, focal neurologic 
symptoms, and change in mental status. 
http://health-pictures.com/images/Pheochromocytoma.jpg clevelandclinicmeded.com/medicalpubs/diseasemanagement/endocrinology/diseases-of-the-adrenal-gland/ 
Pheochromocytoma 
Diagnosis 
• The diagnosis can be established by measuring catecholamines 
and metanephrines in plasma (blood) or through a 24-hour urine 
collection 
• Care should be taken to rule out other causes of adrenergic 
(adrenalin-like) excess like hypoglycemia, stress, exercise, and 
drugs affecting the catecholamines like stimulants, methyldopa, 
dopamine agonists, or ganglion blocking antihypertensives  
• Various foodstuffs (e.g. coffee, tea, bananas, chocolate, cocoa, 
citrus fruits, and vanilla) can also affect the levels of 
urinary metanephrine and VMA (vanillylmandelic acid) 
• Imaging studies  of the head, neck, and chest, and abdomen can 
help localize the tumor.   
https://en.wikipedia.org/wiki/Pheochromocytoma#Diagnosis 
Pheochromocytoma 
Imaging Studies 
Computer 
tomography showing 
a 2 cm left adrenal 
mass 
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382009000100005 
Magnetic resonance 
imaging showing large  
right adrenal mass 
(arrows) 
Magnetic 
resonance imaging 
showing large 
adrenal mass 
Pheochromocytoma 
Treatment 
• Surgical resection of the tumor is the treatment of first choice 
• Either surgical option requires prior treatment with the non-
specific and irreversible alpha adrenoceptor blocker 
phenoxybenzamine or a short acting alpha antagonist 
(e.g. prazosin, terazosin, or doxazosin) 
• Once the pheochromocytoma has been resected, thereby 
removing the major source of circulating catecholamines, a 
situation arises where there is both very low sympathetic activity 
and volume depletion; this can result in profound hypotension  
• Therefore, it is usually advised to "salt load" pheochromocytoma 
patients before their surgery.  
https://en.wikipedia.org/wiki/Pheochromocytoma#Diagnosis 
Adrenal Hyperandrogenism 
The Adrenal Glands as the Source of Androgens 
• The adrenal glands are an important source of androgens, 
especially in children and women 
• The primary adrenal androgens, dehydroepiandrosterone (DHEA) 
and dehydroepiandrosterone sulfate (DHEAS sulfate), are under 
ACTH control and have little intrinsic androgenic activity 
• However, they are converted to androstenedione and then to 
testosterone (and estrogen) in both the adrenal gland and 
peripheral tissues 
• DHEA and DHEA sulfate are responsible for adrenarche (pubic hair 
development) 
• Peak levels occur in the third decade of life and decline 
progressively to 25% of peak levels around the age of 80 years. 
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Adrenal Hyperandrogenism 
Clinical Manifestations in Childhood 
• In female neonates, androgen excess causes female 
pseudohermaphroditism (ambiguous genitalia) 
• Male infants exhibit penile enlargement  
• At prepuberty androgen excess manifests as increased rate of 
growth in height and skeletal maturation with premature 
epiphyseal fusion and short adult height; boys exhibit penile 
enlargement, hair growth in androgen-dependent areas, 
deepening of the voice, and other secondary sexual characteristics; 
girls have hirsutism, acne, and clitoromegaly 
• At puberty androgen excess causes premature skeletal maturation 
and short adult height in boys, and amenorrhea, different degree 
of virilization, and increased skeletal maturation, resulting in short 
adult height In girls. 
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Adrenal Hyperandrogenism 
Clinical Manifestations in Adults 
• In men, a decrease in size of the testicles, testosterone secretion, 
and spermatogenesis caused by inhibition of gonadotropin 
secretion may occur 
• In women, hirsutism, acne, menstrual irregularities, male pattern 
baldness, infertility, decreased breast tissue, increased muscle 
mass, android body habitus, and clitoromegaly may occur.   
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Adrenal Hyperandrogenism 
Management  
• Management of hyperandrogenism symptoms 
• The use of antiandrogens such as cyproterone 
acetate, spironolactone, and flutamide  
• Cyproterone acetate is a synthetic steroidal antiandrogen, 
progestin, and antigonadotropin 
• Spironolactone is aldosterone antagonists 
• Flutamide is a synthetic, non-steroidal antiandrogen  
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Nonclassic Congenital Adrenal Hyperplasia 
• Nonclassic congenital adrenal hyperplasia is characterized by 
milder enzyme dysfunction and manifests commonly in 
adolescence or adulthood 
• Although some patients with NCAH may be asymptomatic, 
hirsutism is the most common symptom 
• The ACTH stimulation test is the best screening test for evaluating 
adrenal gland functions 
• Asymptomatic patients with NCAH do not need glucocorticoid 
treatment 
• If the main concern of the patient is infertility, ovulation induction 
is the treatment of choice 
• If the patient seeks medical advice because of hirsutism, anti-
androgens may be used.   
http://www.ncbi.nlm.nih.gov/pubmed/17551465 
Androgen-Secreting Adrenal Tumors 
• Primary adrenocortical carcinoma may be associated with excess 
androgen secretion, and sometimes cortisol may also occur 
• Primary adrenocortical carcinoma is a rare disease, with an 
incidence of 1 per 600,000 to 1,600,000 and a prevalence of 4 to 
12 per 1,000,000 
• Female patients may exhibit virilization with very high levels of 
DHEA sulfate (500 μg/dL or higher), testosterone, and urinary 17-
ketosteroids 
• Primary adrenocortical carcinomas are highly malignant, with a 
poor prognosis 
• Tumors are usually larger than 6 cm, invade the capsule, 
metastasize early, and typically recur after surgery.  
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Adrenal Incidentaloma 
• Adrenal masses are often discovered incidentally and are then 
termed adrenal incidentalomas  
• The differential diagnosis of adrenal incidentaloma includes many 
primary, metastatic, benign, and malignant entities  
• The treatment for a hormonally active (functional) adrenal 
incidentaloma is surgery 
• The treatment for a malignancy depends on the cell type, spread, 
and location of the primary tumor 
• Nonfunctional adrenal incidentaloma is not premalignant, and 
surgical excision is not indicated. 
 
http://emedicine.medscape.com/article/116587-overview 
Considerations of the Pharmacologic use  
of Glucocorticoids 
• Pharmacologic doses of synthetic glucocorticoids are used in a 
wide variety of diseases for their anti-inflammatory and 
immunosuppressive effects 
• Two main clinical problems arise with the chronic use of 
pharmacologic doses of glucocorticoids, iatrogenically induced 
Cushing’s syndrome and adrenal insufficiency on abrupt cessation 
of therapy 
• Alternate-day therapy and avoidance of nighttime doses are 
associated with less suppression of the hypothalamic–pituitary–
adrenal axis after discontinuation of glucocorticoid therapy.   
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Prognosis and Prophylaxis 
  
• Prognosis depends strictly from the diseases nature, their 
clinical manifestations,  quality of treatment and compliance 
of all its prescriptions 
• There are no known lifestyle changes to lower the risk of 
developing essential adrenal gland disorders  
• The following dietary and lifestyle considerations may support 
healthy adrenal function: avoiding simple carbohydrates, 
calorie restriction, limiting stimulants, exercising, maintaining 
a positive outlook and good self esteem, adequate sleep at 
regular intervals, etc.  
 
http://www.lifeextension.com/Protocols/Metabolic-Health/Adrenal-Disorders/Page-07 
Abbreviations  
ACTH – adrenocorticotropic hormone 
AI - adrenal insufficiency  
AIDS - acquired immune deficiency 
syndrome 
AH - adrenal hyperfunction 
APA - aldosterone-producing adenoma  
DST - 1-mg dexamethasone 
suppression test 
CRH - corticotropin-releasing hormone 
CS - Cushing’s syndrome 
CST - cosyntropin (Cortrosyn) 
stimulation test 
CT - computed tomography   
DHEA - dehydroepiandrosterone 
DHEAS - dehydroepiandrosterone 
sulfate 
ICU -intensive care unit 
ID – identification 
IHA -  idiopathic hyperaldosteronism 
IV – intravenous  
IPSS - International Prognostic Scoring System 
FH - familial hyperaldosteronism 
GRH - glucocorticoid-remediable 
hyperaldosteronism  
LDDST - low dose dexamethasone 
suppression test 
MRI - magnetic resonance imaging 
NCAH - nonclassic congenital adrenal 
hyperplasia  
PH – primary hyperaldosteronism 
UFC - 24-hour urinary free cortisol 
determination 
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